Fig. 1From: Valsartan reduces NOX4 expression and halts diabetic nephropathy in streptozotocin induced diabetic rat modelBlood glucose level in the studied groups at the start point {before induction of diabetes} (a) and end point {after 4 weeks of valsartan treatment} (b) presented as mean ± SEM, **p, ##p ˂ 0.01, (*) compared to GpI: normal group, (#) compared to GpII: DN groupBack to article page